Navigation Links
Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
Date:3/19/2013

nse, offset by a $0.9 million decrease in consulting fees and legal expenses.

Balance Sheet Highlights
As of December 31, 2012, the Company had cash, cash equivalents and short-term investments totaling $36.5 million. Stockholders' equity amounted to $41.8 million as of December 31, 2012.  The Company's contingent asset related to the consideration for the acquisition of SynthRx in April 2011 was settled in December 2012.  The Company recorded the fair value of the contingent asset as of the settlement date as an adjustment to equity and recognized as a transaction-related expense the increase in its fair value as of its settlement date relative to December 31, 2011.

About Mast Therapeutics
Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, CA.  The Company is leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from over two decades of clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers, to develop MST-188, its lead product candidate, for serious or life-threatening diseases with significant unmet needs.  MST-188 is a cytoprotective, hemorheologic, anti-inflammatory and anti-thrombotic agent that has potential utility in diseases or conditions characterized by microcirculatory insufficiency (endothelial dysfunction and/or impaired blood flow). 

The Company is recruiting subjects in EPIC, a pivotal phase 3 study of MST-188 in sickle cell disease.  The Company plans to initiate a phase 2 clinical study of MST-188 in acute limb ischemia, a complication of peripheral arterial disease, in late 2013 or early 2014.  More information can be found on the Company's web site at www.masttherapeutics.com.

Forward Looking Statements
Mast Therapeutics cautions you that statements included in this press release that are
'/>"/>

SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Echo Therapeutics Achieves ISO 13485 Certification
2. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3. Echo Therapeutics Appoints Robert Doman to Board of Directors
4. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
5. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
6. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
7. PTC Therapeutics Closes $60 Million Private Financing
8. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
9. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
10. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Inhibikase Therapeutics, Inc., an emerging leader in infectious ... new results on its antiviral program to ,prevent, ... PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, Roche ... causative agent of Progressive Multifocal Leukoencephalopathy (PML). IkT-001Pro, ... release formulation, can clear JC polyomavirus (JCV) infection ...
(Date:5/23/2013)... , May 23, 2013  PAREXEL International Corporation ... will be presenting at the Jefferies Healthcare Conference in ... Vice President and Chief Financial Officer, will be making ... 1:30 p.m. ET on Monday, June 3, 2013. ... through the "Investors" section of PAREXEL,s website at ...
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2PAREXEL International To Present At Jefferies Healthcare Conference 2Aribex Unveils New Color of NOMAD Pro 2 2
(Date:5/23/2013)... May 23, 2013 To better ... DORMA company, is pleased to announce the release ... for its pacesetting space division products. Provided by ... wallcoverings, the new patterns and colors represent a ... Through meetings with a team of Koroseal experts, ...
(Date:5/23/2013)... NY (PRWEB) May 23, 2013 A ... York Supreme Court (reference number 110504/2009) by Lori Mandel, ... verdict awarding Ms. Mandel $8.6 million. Ms. Mandel sought ... alleged misdiagnosis led to further complications that affected the ... her work. , The plaintiff alleged that her doctor ...
(Date:5/23/2013)... PETA International Science Consortium, Ltd., issued the following ... of 2013: , Reform of chemical safety legislation ... testing. , Ensuring the safety and appropriate ... Reforming the EPA,s Toxic Substances Control Act is ... Council,s vision for transforming toxicity testing "from a ...
(Date:5/23/2013)... techniques in imaging of brain activity developed by ... Institute, and his colleagues lead to improved treatment ... of electroencephalogram (EEG) and functional magnetic resonance imaging ... areas generating epileptic seizures, giving neurosurgeons a better ... appropriate. These results were presented at the ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- The success of an ... with a serious airway malformation sheds light on new technology ... report in the May 23 New England Journal of ... At first, the baby born five weeks early seemed perfectly ... when he was 6 weeks old. Just two weeks later, ...
Breaking Medicine News(10 mins):Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3
... News) -- Women, older people and minorities are under-represented in ... a new study. Researchers say that this could ... new treatments among these groups, particularly the elderly. "Our ... drugs do not represent well the U.S. population who may ...
... media fans to comment in 140 characters or less on ... toll or the great taste of a grilled cheese sandwich. ... banter, is it possible to also track important public health ... a one-word tweet: "Yes!" Mark Dredze and Michael J. ...
... A new study published in The Journal of ... such as weight problems, physical inactivity, high alcohol consumption, ... dysfunctions in men. Additionally, an unhealthy lifestyle is more ... by Associate Professor Morten Frisch, MD, PhD, DSc, of ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, July 6 ... steak or a hot fudge sundae, consider this: The high you ... one you might feel if you smoked marijuana. The ... is, a nearly irresistible desire to eat -- appears to help ...
... of bone mass during space travel and with long duration ... to an increased risk of fractures. When the final mission ... 8, an animal experiment to test a novel therapy to ... a consortium of scientists from Beth Israel Deaconess Medical Center ...
... are typically ones headed by a medical doctor rather than a ... what makes a good hospital. The research, to be published ... the first of its kind. Its conclusions run counter to ... managers -- not those with a medical degree -- at the ...
Cached Medicine News:Health News:Patient Disparities Seen in Lung Cancer Drug Trials 2Health News:You are what you tweet: Tracking public health trends with Twitter 2Health News:You are what you tweet: Tracking public health trends with Twitter 3Health News:An unhealthy lifestyle is associated with sexual dysfunction 2Health News:Binge Eating May Be a High All Its Own 2Health News:Binge Eating May Be a High All Its Own 3Health News:Experiment aboard shuttle Atlantis will test novel therapy to build bone during space travel 2Health News:The best hospitals are run by physicians 2
The cemented hip joint prosthesis system....
The uncemented hip joint prosthesis system...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: